Gj. Quinlan et al., PLASMA FATTY-ACID CHANGES AND INCREASED LIPID-PEROXIDATION IN PATIENTS WITH ADULT-RESPIRATORY-DISTRESS-SYNDROME, Critical care medicine, 24(2), 1996, pp. 241-246
Objective: There is strong evidence that adult patients with acute res
piratory distress syndrome (ARDS) are under severe oxidative stress, w
hich leads to molecular damage. Using gas chromatography-mass spectrom
etry, our objective was to sequentially monitor changes, in intensive
care unit (ICU) patients, characteristic of the oxidative loss of plas
ma unsaturated fatty acids and formation of the highly specific oxidat
ion product of linoleic acid, 4-hydroxy-2-nonenal. Design: Prospective
, nonintervention, descriptive study, Limited statistics were applied
to facilitate interpretation of the data. Setting: ICU of a postgradua
te teaching hospital. Patients: Eighteen critically ill patients with
an established diagnosis of ARDS requiring high F10(2) administered by
mechanical ventilation were compared with ten normal, healthy control
s and ten patients pre- and postcardiopulmonary bypass surgery at risk
for developing ARDS. Interventions: None. Measurements and Main Resul
ts: Sixty percent of the patients with ARDS included in this study sur
vived. Major changes in the plasma concentrations of fatty acids occur
red in all patients during their stay in the ICU. Percentage decreases
in plasma linoleic acid concentrations were accompanied by increases
in plasma oleic and palmitoleic acid concentrations. Circulating linol
eic acid concentrations were significantly (p = .0001) lower in patien
ts with ARDS than in the two control groups, The patients with ARDS wh
o did not survive had lower (p = .0056) plasma oleic acid values than
normal healthy controls and patients at risk for ARDS as a consequence
of undergoing cardiopulmonary bypass surgery. Changes in palmitoleic
acid, however, did not reach significance within the different groups
studied. Patients with ARDS showed higher plasma concentrations of 4-h
ydroxy-2-nonenal (0.433 +/- 0.048 vs. 0.523 +/- 0.069 nmol/mL plasma f
or survivors and nonsurvivors, respectively) when compared with normal
healthy controls (0.205 +/- 0.03 nmol/mL, p = .0001) and cardiopulmon
ary bypass patients at risk for developing ARDS (0.279 +/- 0.027 nmol/
mL, p = .034 prebypass). Conclusions: During intensive care treatment,
patients with ARDS decrease their percentage plasma concentrations of
total plasma linoleic acid, but increase their percentage concentrati
ons of oleic and palmitoleic acids. As plasma linoleic acid concentrat
ions decreased, there was usually an increase in plasma 4-hydroxy-2-no
nenal values, one of its specific peroxidation products, suggestive of
severe oxidative stress leading to molecular damage to lipids.